Welcome to our dedicated page for Marex Group SEC filings (Ticker: MRX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Marex Group's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Marex Group's regulatory disclosures and financial reporting.
Marex Group plc is offering Autocallable Fixed Income Barrier Notes linked to the worst performing of ONON, UBS and AVGO, with a $1,000 principal amount per Note and monthly fixed interest of 1.334% per month (equivalent to 16.008% per annum). The Notes have monthly call observation dates beginning July 8, 2026, a Final Valuation Date of December 1, 2027 and a scheduled maturity of December 8, 2027. If not called, principal repayment at maturity depends on the Reference Return of the Worst Performing Underlying and may result in loss of up to 100% of principal if the Final Value is below the Barrier Value (50% of Initial Value).
Marex Group plc is offering Autocallable Leveraged Barrier Notes linked to the Russell 2000 Index. The notes have a $1,000 principal amount per note, an upside participation rate of 150%, and a barrier at -30%. If the index is at or above 100% of its initial value on the Call Observation Date, the notes will be automatically called with at least an 11.50% call premium. If not called, maturity payments vary: positive reference returns receive leveraged upside; modest declines down to -30% return principal; declines below -30% deliver 1:1 losses, potentially wiping out principal. All payments are subject to the credit risk of Marex and the Estimated Initial Value is expected to be between $940.00 and $990.00 per note.
Marex Group plc is offering Capped Leveraged Buffered Notes linked to the worst performing of the EURO STOXX 50® Index and the iShares® MSCI EAFE ETF. Each Note has a $1,000 principal amount, 200% Upside Participation, a Buffer Percentage of -10%, and a Maximum Return of at least 30%. The Notes mature on December 29, 2027. If the worst performing underlying finishes above its initial value, investors receive leveraged upside subject to the Maximum Return; if it finishes between 0% and -10% the principal is returned; below -10% losses are amplified by a Downside Leverage Factor (~111.11%). The Notes do not pay interest and are senior unsecured obligations of Marex, exposing holders to Marex credit risk and limited liquidity. The Estimated Initial Value is expected between $950 and $990 per Note on the Pricing Date.
Marex Group plc is offering Autocallable Contingent Income Barrier Notes linked to the worst performing of the S&P 500®, Russell 2000® and Nasdaq-100 Technology Sector Index® with a $1,000 principal amount per Note and a scheduled maturity of June 28, 2028. The Notes pay a quarterly contingent coupon (at least 11.252% per annum equivalent to $28.13 per $1,000 per quarter if payable) when each underlying is at or above its coupon trigger. The Notes may be automatically called early if each underlying is at or above 100% of its initial value on a Call Observation Date, in which case holders receive principal plus the applicable contingent coupon. At maturity, if not called, payment depends on the Reference Return of the Worst Performing Underlying: if that return is >= -30.00% you receive principal plus final contingent coupon; if below -30.00% you absorb downside on a one-for-one basis and may lose up to 100% of principal. The document highlights Marex credit risk, limited liquidity, possible conflicts of interest as calculation agent, uncertain U.S. federal tax treatment, and that the Estimated Initial Value will be less than the public price.
Marex Group plc Chief Executive Officer Ian T. Lowitt reported a routine tax-related share disposition. On this Form 4, 39,478 ordinary shares were withheld to satisfy tax withholding obligations tied to the vesting of previously granted deferred bonus plan awards, rather than being sold on the open market.
After this withholding, Lowitt directly holds 2,868,501 ordinary shares. This figure includes 194,411 shares underlying deferred bonus plan awards that represent contingent rights to receive one ordinary share each upon future vesting and settlement.
Marex Group plc Chief Financial Officer Rob Irvin reported an automatic tax-related share disposition tied to deferred bonus awards. On the vesting of previously reported deferred bonus plan awards, 3,358 ordinary shares were withheld to satisfy the associated tax withholding obligation, using a reference price of $54.45 per share.
After this withholding, Irvin holds 34,746 ordinary shares directly, including 25,300 shares underlying deferred bonus plan awards that represent contingent rights to receive one ordinary share each upon future vesting and settlement.
Marex Group plc executive Thomas Texier, Group Head of Clearing, reported a tax-related share disposition. On May 22, 2026, 19,640 ordinary shares were withheld to satisfy tax withholding obligations tied to the vesting of previously reported deferred bonus plan awards. The value per share was $54.45, the closing price of Marex’s ordinary shares on Nasdaq on May 21, 2026. Following this withholding, Texier is reported as holding 208,591 ordinary shares, which includes 150,563 shares underlying deferred bonus plan awards that provide a contingent right to receive one ordinary share upon vesting and settlement. This transaction reflects tax withholding rather than an open-market sale.
Marex Group plc President Simon Van Den Born reported a tax-related share disposition tied to deferred bonus awards. On the vesting of previously granted deferred bonus plan awards, 43,712 ordinary shares were withheld to satisfy his tax withholding obligation, using a reference price of $54.45 per share, the closing price on May 21, 2026. After this withholding, he beneficially owns 1,465,252 ordinary shares, which the filing notes includes 272,659 shares underlying deferred bonus plan awards that represent contingent rights to receive one ordinary share per award upon future vesting and settlement.
Marex Group plc executive Paolo Tonucci reported a tax-withholding share disposition related to equity compensation, not an open-market trade. On this Form 4, 31,080 ordinary shares were withheld on May 22, 2026 to satisfy tax obligations tied to the vesting of previously granted deferred bonus plan awards at a reference price of $54.45 per share.
After this withholding, Tonucci directly holds 1,315,609 ordinary shares, which the filing notes includes 220,746 shares underlying deferred bonus plan awards that will be delivered only upon future vesting and settlement. The transaction reflects routine tax administration on compensation rather than a discretionary sale.
Marex Group plc reported that Nilesh Jethwa, CEO of Marex Solutions, had 39,661 Ordinary Shares withheld on May 22, 2026 to satisfy tax obligations tied to the vesting of previously granted deferred bonus plan awards. This was recorded at a reference price of $54.45 per share and reflects a tax-withholding disposition rather than an open market sale. After this withholding, Jethwa beneficially owns 247,354 Ordinary Shares, which include 111,183 shares underlying deferred bonus plan awards that will be delivered upon future vesting and settlement.